Controlled formulation of doxorubicin-polylactide nanoconjugates for cancer drug delivery.
National Institute of Standards and Technology, Boulder, CO 80305, USA.Conference proceedings: ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 01/2009; 2009:2400-2. DOI:10.1109/IEMBS.2009.5334938 pp.2400-2
ABSTRACT We report here the synthesis of doxorubicin-polylactide conjugate via doxorubicin-initiated lactide polymerization.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.